Clinical trial
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic…
NCT00461617 · Kissei Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00461617 |
|---|---|
| Title | Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients |
| Official title | Multicentre, Double-Dummy, Randomized, Double-Blind Comparison Between Mitiglinide and Nateglinide in the Patients With Type 2 Diabetes |
| Lead sponsor | Kissei Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes |
| Intervention type | Drug |
| Interventions | Mitiglinide |
| Enrollment | 291 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Apr 18, 2007 |
| Last update posted | Oct 21, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: